What makes iQ’s a.m./p.m. age-defying eye therapy so effective?

  • 2 powerful day & night products
  • Clinically proven ingredients
  • The only concealer that works like eye cream!

    iQ’s a.m./p.m age-defying eye therapy combines two treatments, iDisguise and RestorEyes, that are absolutely loaded with accelerated, concentrations of multiple active ingredients.

    You won’t find these ingredients in any other daytime concealer — iDisguise is the first and only concealer infused with Haloxyl, Dermaxyl and Eyeliss. And you won’t find higher concentrations of this formulation in any other nighttime cream — RestorEyes has 41% active ingredients.

  •  
    Each iQ products contains a specific combination of Intelligent Ingredients designed to achieve the most desirable results.
     
    iDisguise Firming Eye Concealer
    Intelligent Ingredients:
     

    Haloxyl
    Targets the underlying cause of dark circles, excess pigmentation, to lighten and brighten the eye area. Proven to reduce the appearance of dark circles.

       
    Dermaxyl
    Clinically proven to reduce the appearance of deep wrinkles.
       
    Eyeliss
    Relieves puffiness and shrinks
    under-eye bags by improving fluid flow
    and firming saggy skin.
     
      RestorEyes Firming Eye Therapy
    Intelligent Ingredients:
    Haloxyl
    Uses natural enzymes to break down blood from leaked capillaries that causes dark circles. Also helps strengthen the capillaries so they stop leaking in the first place.
       
    Grantox
    Mimics the effect of Botox® without the pain and price of injections. Effectively interferes with the signaling process of the nerves, relaxing the muscles and softening out the creases around the eyes.
       
    Dermaxyl
    A powerful peptide complex that decreases the volume and depth of eye wrinkles.
       
     

    Did you know?
    iQ’s Intelligent Ingredients …

    • have been proven to fight the visible signs of aging in clinical studies
    • are so advanced that they’re protected by numerous patents in both the U.S. and Europe